Infertility Treatment Market is forecast to grow at a robust CAGR of 8% between 2022 and 2032 | Exclusive Report by FMI

As per the infertility treatment market report, factors such as a decrease in global fertility rates, increased adoption of various infertility procedures, an increase in the number of fertility clinics worldwide, an increase in public and private investments, and the presence of advanced infertility treatment products in the market are expected to boost the demand for fertility services.

Physical inactivity, a continued move toward a sedentary lifestyle, improper fetal care, deferred pregnancy, smoking, excessive alcohol consumption, stress, and other factors have all contributed to an increase in the number of infertility cases.

Furthermore, an increase in the incidence of diabetes and obesity is a significant factor contributing to the rise in these illnesses’ rates. The worldwide infertility treatment market is driven by an increase in the number of fertility clinics around the world and advancements in technology to treat infertility in both men and women.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-14317

In addition, increased governmental and private sector investments in the healthcare industry have created a favorable infertility treatment market outlook for expansion.

A significant increase in reproductive clinics has occurred, despite a global fall in fertility rates. Along with this, the increased focus of players and governments on opening and acquiring additional fertility facilities around the world is expected to contribute to the segment’s rise. In addition, the proliferation of fertility clinics equipped with innovative technologies is expected to expand infertile couples’ access to infertility treatment options.

However, in the coming years, the high cost of operations associated with reproductive approaches, as well as other issues such as lower efficacy among elderly women, are expected to be essential restrictions on demand for infertility treatment.

The infertility treatment market key developments project that over the projection period, the hospital and surgical clinics category is expected to increase significantly. Other departments, such as neonatal critical care units, help to support hospitals. In addition, hospitals provide extensive maternity care even after the delivery of a child.

The market is expected to grow as a result of government initiatives to increase the number of multispecialty hospitals with departments that perform infertility treatment procedures like IVF, as well as the growing number of surgical centers that provide surgical procedures for the treatment of infertility.

The infertility treatment market is projected to reach US$ 2.2 Bn by 2026.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-14317

Key Takeaways

• From 2021 to 2026, the Asia Pacific infertility treatment market share is expected to grow at the fastest rate of 9.1%.
• The growth of the infertility treatment market opportunities in Asia is being aided by the development of healthcare infrastructure and development in discretionary spending, rising medical tourism in Asian countries, rising healthcare expenditure, and rising awareness among people about infertility.
• The number of patients conducting IVF cycles dropped by 90 percent during the COVID-19 pandemic. COVID-19’s spread has influenced fertility clinics, resulting in the cancellation of IVF treatments, as well as fertility decisions among couples that were considering IVF treatment before the pandemic.
• During the projected period, the equipment segment is expected to increase at the fastest rate. Due to technical improvements and the existence of well-established players with a diverse product range, this market has experienced rapid expansion, and the emerging trends in the infertility treatment market are also portraying a positive picture.

“Infertility treatment treatments are becoming more widely available, and the number of fertility clinics is expanding. Increased public and private investments, as well as technical improvements, are likely to drive market expansion in the future years.”, opines an FMI analyst.

Competitive Landscape

• Cooper Companies Inc.
• Vitrolife
• Cook Group
• Thermo Fisher Scientific Inc.
• Kitazato Corporation
• FUJIFILM Irvine Scientific
• Hamilton Thorne Ltd. (US)

Vitrolife, the industry leader in time-lapse systems for assisted reproduction, released EmbryoScope+ in March 2019 in China, the world’s largest market for IVF treatments.

Key SegmentsBy Product:

• Equipment
  • Microscopes
  • Imaging Systems
  • Sperm Analyser Systems
  • Ovum Aspiration Pumps
  • Micromanipulator Systems
  • Incubators
  • Gas Analyzers
  • Laser Systems
  • Cryosystems
  • Sperm Separation Devices
• Media & Consumables
• Accessories

Are you looking for customized information related to the latest trends, drivers, and challenges? Speak to Our Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-14317

By Procedure:

• Assisted Reproductive Technology
  • In Vitro Fertilization
    • Intracytoplasmic Morphologically Selected Sperm Injection
    • Gamete Donation
  • Intracytoplasmic Sperm Injection
  • Surrogacy
• Artificial Insemination
  • Intrauterine Insemination
  • Intracervical Insemination
  • Intratubal Insemination
• Fertility Surgeries
  • Laparoscopy
  • Hysteriscopy
  • Varicocelectomy
  • Laparotomy
  • Tubal Ligation Reversal
  • Micrsurgical Reconstruction
    • Vasovasostomy
    • Vasoepididymostomy
• Other Infertility Treatment Procedures

By Patient Type:

• Female Infertility Treatment
• Male Infertility Treatment

By End User:

• Fertility Centre’s
• Hospitals & Cergical Clinics
• Cryobanks
• Research Institutes

More Trending Reports by Future Market Research:

Dental Crown Removal Market Size: The dental crown removal market is estimated to secure a valuation of US$ 294.59 million in 2023 and is predicted to reach US$ 461.9 million by 2033. The market is capturing a CAGR of 4.6% during the forecast period.

APOL1 Mediated Kidney Disease Market Share: The global APOL1 mediated kidney disease market is expected to attain a valuation of USD 3779.9 million in 2023 and is projected to reach USD 5753.9 million by 2033, trailing a CAGR of 4.3% during the forecast period.

Botulinum Toxin-coated Microneedles Market Growth: According to Future Market Insights (FMI), analysis in a recent market survey estimated that the global botulinum toxin-coated microneedles market will be valued at US$ 109.6 Million in 2024 and is expected to reach US$ 268.1 Million by 2033.

About FMI:

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs